Molly Schneider
Research Assistant
Working groups
Background
Molly completed her Bachelor of Science with Honours in 2016 at the University of Melbourne. Her research project was carried out at Bio21 and investigated the sexual stage development of the malaria parasite Plasmodium falciparum. After completing her degree, she worked as a research assistant in a Cell Signalling laboratory. Her work helped to understand the formation and components of nuclear bodies in the neurodegenerative disease SCA1.
Molly is currently working in the Malaria Virulence and Drug Discovery group. She is assisting in determining the mechanism of action of potential anti-malarial drugs, whilst providing support in the laboratory.
Qualifications
- 2016: BSc (Hons), University of Melbourne
Positions
- 2017-2019: Research Assistant, Cell Signalling, University of Melbourne
- 2016-2017: Research Assistant, Malaria, University of Melbourne
Burnet publications
View 9 more
Sequence elements within the PEXEL motif and its downstream region modulate PTEX‐dependent protein export in Plasmodium falciparum
Traffic
Mikha Gabriela et al
PTEX helps efficiently traffic haemoglobinases to the food vacuole in Plasmodium falciparum
PLoS Pathogens
Thorey K. Jonsdottir et al
The delayed bloodstream clearance of Plasmodium falciparum parasites after M5717 treatment is attributable to the inability to modify their red blood cell hosts
Frontiers in Cellular and Infection Microbiology
Molly Parkyn Schneider et al
Past projects
Discovering novel antimalarials to block parasite virulence
Drugs are the main weapons used to combat malaria infection, but parasites are becoming resistant and new medicines and drug targets are needed.
Drug resistance and mechanism of action studies
We work with medicinal chemists to develop new antimalarials that are effective against already multi-drug resistant parasites.